What were some of your most satisfying successes of the past year, and why? It’s always exciting when a deal is identified as the first-of-its-kind, as in the GW Pharmaceuticals acquisition by Jazz Pharmaceuticals, which was the largest cannabis industry deal to date. Similarly, the Johnson & Johnson separation is definitely a highlight of the past year. Being able to guide them through this transformative time is a huge tribute to the Firm’s lasting relationship and our ability to give commercial advice.

Just as important as these innovative deals is continuing to work with a client I’ve advised on approximately 100 transactions, and I consider my sustained relationship with IBM to be an ongoing success.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]